Moore administration purchases surplus of Mifepristone

Maryland- On Friday the Moore administration announced a partnership with the Maryland Department of Health in order to purchase a substantial amount of  the abortion drug Mifespristone.

This announcement comes on the heels of a Texas case in which a federal judge suspended FDA approval of the drug last week, which the Supreme Court then temporarily restored full access to the drug on Friday in order to review the court decision.

Following this announcement multiple states have purchased vast quantities of the drug to create stockpiles if needed.

A statement from the Moore administration said in part quote: “As a member of the Reproductive Freedom Alliance, Maryland will not stand for this assault on women’s health care. This purchase is another example of our Administration’s commitment to ensure Maryland remains a safe haven for abortion access and quality reproductive health care.”